British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidineThe British drugmaker GSK has struck an agreement to make a payment of up to $2.2bn (£1.7bn) to resolve litigation brought in the US over its heartburn treatment Zantac.The company said it had struck agreements with 10 plaintiff law firms who represent about 93%, roughly 80,000, of the US state court product liability cases pending against it. Continue reading…
Source link : https://www.theguardian.com/business/2024/oct/09/gsk-strikes-22bn-deal-to-resolve-legal-cases-in-us-over-heartburn-treatment-zantac
Author : Jane Croft
Publish date : 2024-10-09 18:43:21
Copyright for syndicated content belongs to the linked Source.
GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac
